Cautery | Brain Vascular Malformation Consortium

Skip to main content

Search

Join Our Contact Registry

Header Social Media

Our Research
Patient and Families
Researchers and Clinicians
Early Stage Investigators
News and Events
- Latest News
About Us

An NIH-Funded Rare Diseases Clinical Research Network Consortium

A small electric needle that is applied to burn tissue. This is sometimes used in HHT to treat telangiectases and control bleeding.

Footer menu

Web Policies
Rare Diseases Clinical Research Network
Genetic and Rare Diseases Information Center
Members Login
Contact Us

The Brain Vascular Malformation Consortium (BVMC) is part of the Rare Diseases Clinical Research Network (RDCRN), which is funded by the National Institutes of Health (NIH) and led by the National Center for Advancing Translational Sciences (NCATS) through its Division of Rare Diseases Research Innovation (DRDRI). BVMC is funded under grant number U54NS065705 as a collaboration between NCATS and the National Institute of Neurological Disorders and Stroke (NINDS). This website is hosted by the network’s Data Management and Coordinating Center at Cincinnati Children’s Hospital Medical Center, which is funded by NCATS and NINDS under grant number TR002818. The content of this website is solely the responsibility of the BVMC administrative coordinating center at University of California, San Francisco and does not necessarily represent the official views of the NIH.

social media